This localized sensation is common with subcutaneous GLP-1 medications and typically resolves within seconds to minutes, but understanding what causes it and how to minimize discomfort can help you feel more confident with your treatment routine
PlexusDx's precision-wellness approach helps you evaluate these factors alongside clinical evidence to support a more informed conversation with your healthcare provider
Whether you need metabolic support, performance preservation, or long-term fat loss, a physician-guided weight loss program using these medications can make the difference.Ready to take control of your body composition, energy, and training results
This class of medications is becoming a household name, not only for their implications for weight loss but also for their effect on cardiovascular disease
The same trial also notes that the SEMALEAN study (2025): "Patients experienced an average weight loss of 12 kg after 6 months of treatment with Semaglutide", showing significant total-body change along with the internal change
Values derived from different clinical studies (not head-to-head)
